What would it take to make cooperative enterprises viable at scale in the life sciences ecosystem? How can these models attract investment while preserving their core values? And could they unlock more resilient, inclusive, and patient-centered innovation systems? This roundtable will bring together leaders from healthcare, industry, policy, and cooperative movements to explore the opportunities and limitations of rethinking enterprise models in pharma and beyond.
Participantes propuestos- Representante de RPK (si hubiera opción, pendiente de confirmación)
- Representante de una institución vasca (si hubiera opción, pendiente de confirmación)
